Nanfang Hospital, Southern Medical University
Nanfang Hospital, Southern Medical University
Guangzhou, China15 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Large Language Model-Based Emotional Management for Breast Cancer Patients | Primary Breast Cancer | Active, not recruiting | Not applicable | 2026-09-22 | NCT07452055 | |
| A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG) | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Not yet recruiting | Phase 4 | 2026-09-21 | NCT07832201 | |
| A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis. | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 2 / Phase 3 | 2026-08-14 | NCT06447597 | |
| Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation | EBV Infection After Allogenic HSCT | Recruiting | Not applicable | 2026-07-23 | NCT07693881 | |
| PEI-GT Trial for Initial Treatment of Primary Open-Angle Glaucoma With Cataract | cataract, eye disorder, glaucoma, lens disorder, ocular hypertension, open-angle glaucoma | Recruiting | Not applicable | 2026-07-14 | NCT07700498 | |
| Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 1 | 2026-03-16 | NCT07176650 | |
| A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Active, not recruiting | Phase 2 | 2026-01-15 | NCT05716087 | |
| Novel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric Tissue | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Not yet recruiting | Not stated | 2025-12-11 | NCT07276854 | |
| Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, thrombocytosis disease | Recruiting | Phase 2 | 2025-11-17 | NCT06552429 | |
| A Clinical Study of HMPL-506 in Patients With Hematological Malignancies | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Phase 1 | 2025-09-29 | NCT06387082 | |
| A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03) | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 3 | 2025-07-20 | NCT06464991 | |
| Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules | Healthy | Recruiting | Phase 1 | 2025-02-12 | NCT06823895 | |
| POEM-F for Achalasia International Study | Deglutition Disorders, Digestive System Diseases, achalasia, digestive system disorder, dyskinesia of esophagus, esophageal disorder, gastroesophageal reflux disease | Recruiting | Not applicable | 2024-12-03 | NCT06042127 | |
| Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, severe hemophilia A | Not yet recruiting | Phase 3 | 2024-06-20 | NCT06136507 | |
| Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2022-08-31 | NCT05334277 |